Bronchoalveolar lavage cell pattern from healthy human lung. 2012

M Heron, and J C Grutters, and K M ten Dam-Molenkamp, and D Hijdra, and A van Heugten-Roeling, and A M E Claessen, and H J T Ruven, and J M M van den Bosch, and H van Velzen-Blad
Department of Pulmonology, Center for Interstitial Lung Diseases, St Antonius Hospital, Nieuwegein, the Netherlands.

Bronchoalveolar lavage (BAL) is widely accepted as a key diagnostic procedure in interstitial lung diseases (ILD). We performed a study to obtain reference intervals of differential cell patterns in BAL fluid with special attention to the origin of lavage fluid, e.g. bronchial/alveolar, to atopy and smoking status and to age of the healthy people. We performed bronchoalveolar lavage in 55 healthy subjects with known atopy status (age: 18-64 years, non-smokers/smokers: 34/21) and determined differential cell counts and lymphocyte subsets in BAL fluid and blood. Moreover, in a subgroup of non-smoking healthy individuals we measured the expression of the regulatory T cell marker forkhead box protein 3 (FoxP3) on blood and BAL fluid lymphocytes in addition to a comprehensive set of activation markers. Differential cell counts from the alveolar lavage fraction differed significantly from calculated pooled fractions (n = 11). In contrast, marginal differences were found between atopic and non-atopic subjects. Interestingly, the BAL fluid CD4(+) /CD8(+) ratio correlated strongly with age (r(2) = 0·50, P < 0·0001). We consider the bronchial and alveolar fraction to be lavage fluid from fundamentally different compartments and recommend analysis of the alveolar fraction in diagnostic work-up of ILD. In addition, our data suggest that age corrected BAL fluid CD4(+) /CD8(+) ratios should be used in the clinical evaluation of patients with interstitial lung diseases.

UI MeSH Term Description Entries
D006969 Hypersensitivity, Immediate Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability. Atopic Hypersensitivity,Hypersensitivity, Atopic,Hypersensitivity, Type I,IgE-Mediated Hypersensitivity,Type I Hypersensitivity,Atopic Hypersensitivities,Hypersensitivities, Atopic,Hypersensitivities, IgE-Mediated,Hypersensitivities, Immediate,Hypersensitivities, Type I,Hypersensitivity, IgE-Mediated,IgE Mediated Hypersensitivity,IgE-Mediated Hypersensitivities,Immediate Hypersensitivities,Immediate Hypersensitivity,Type I Hypersensitivities
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Heron, and J C Grutters, and K M ten Dam-Molenkamp, and D Hijdra, and A van Heugten-Roeling, and A M E Claessen, and H J T Ruven, and J M M van den Bosch, and H van Velzen-Blad
July 1995, Journal of applied physiology (Bethesda, Md. : 1985),
M Heron, and J C Grutters, and K M ten Dam-Molenkamp, and D Hijdra, and A van Heugten-Roeling, and A M E Claessen, and H J T Ruven, and J M M van den Bosch, and H van Velzen-Blad
October 1982, The American review of respiratory disease,
M Heron, and J C Grutters, and K M ten Dam-Molenkamp, and D Hijdra, and A van Heugten-Roeling, and A M E Claessen, and H J T Ruven, and J M M van den Bosch, and H van Velzen-Blad
January 1992, Acta cytologica,
M Heron, and J C Grutters, and K M ten Dam-Molenkamp, and D Hijdra, and A van Heugten-Roeling, and A M E Claessen, and H J T Ruven, and J M M van den Bosch, and H van Velzen-Blad
August 1999, American journal of clinical pathology,
M Heron, and J C Grutters, and K M ten Dam-Molenkamp, and D Hijdra, and A van Heugten-Roeling, and A M E Claessen, and H J T Ruven, and J M M van den Bosch, and H van Velzen-Blad
July 1987, Thorax,
M Heron, and J C Grutters, and K M ten Dam-Molenkamp, and D Hijdra, and A van Heugten-Roeling, and A M E Claessen, and H J T Ruven, and J M M van den Bosch, and H van Velzen-Blad
July 1995, American journal of respiratory and critical care medicine,
M Heron, and J C Grutters, and K M ten Dam-Molenkamp, and D Hijdra, and A van Heugten-Roeling, and A M E Claessen, and H J T Ruven, and J M M van den Bosch, and H van Velzen-Blad
January 1995, Respiratory medicine,
M Heron, and J C Grutters, and K M ten Dam-Molenkamp, and D Hijdra, and A van Heugten-Roeling, and A M E Claessen, and H J T Ruven, and J M M van den Bosch, and H van Velzen-Blad
February 1991, The Annals of thoracic surgery,
M Heron, and J C Grutters, and K M ten Dam-Molenkamp, and D Hijdra, and A van Heugten-Roeling, and A M E Claessen, and H J T Ruven, and J M M van den Bosch, and H van Velzen-Blad
April 1984, Chest,
M Heron, and J C Grutters, and K M ten Dam-Molenkamp, and D Hijdra, and A van Heugten-Roeling, and A M E Claessen, and H J T Ruven, and J M M van den Bosch, and H van Velzen-Blad
January 1992, Respiration; international review of thoracic diseases,
Copied contents to your clipboard!